Keyword: Active Pharmaceutical Ingredients (APIs)

Logistics & Supply Chain

Maximum Safety by Consistent Quality Management

30.04.2015 - The amended EU directive on good distribution practice (GDP) has been in force since 2013. It transfers many principles familiar from pharmaceutical manufacturing to the...

Logistics & Supply Chain

“Supply Chains are 3-dimensional Networks”

30.04.2015 - Because of a rapidly changing world of business and an increase of regulations, the pharmaceutical industry must find new ways to serve patients. CHEManager Distribution &...

Chemistry & Life Sciences

Aesica Secures Continuing FDA Approval of German Sites

03.02.2015 - Aesica it has received continuing FDA approvals for both its bulk manufacturing and packaging operations in Germany. As a consequence, the global pharmaceutical contract...

News

Umicore and Midas Team up in North America

28.01.2015 - Umicore Precious Metals Chemistry has chosen Midas Pharmaceuticals as the exclusive sales agent of the company's Active Pharmaceutical Ingredients (API) segment in the USA and...

Strategy & Management

Camelot’s Pharma Management Radar

19.01.2015 - Despite a positive estimation of the current business climate and an increasing number of products in the pipeline, the global pharmaceutical industry is looking for ways to...

Plant Construction & Process Technology

The EXCiPACT Certification Scheme

05.10.2014 - Excipients, together with an active pharmaceutical ingredient (API), are formulated into a final drug that is either prescribed to a patient by a doctor or bought over-the-counter...

Plant Construction & Process Technology

Pharmaceutical Product Design

05.10.2014 - The final design of a pharmaceutical product is very lengthy and involves several stages. The beginning stage is the drug discovery phase. During this phase, the active...

News

Consort Medical to Acquire Aesica Pharmaceuticals

01.10.2014 - Consort Medica, a UK-based manufacturer of disposable medical devices for drug delivery, has announced it will acquire all shares of German-based Aesica Pharmaceuticals from...